DANIEL REYES-VILLA: Open Payments
NPI 1013136563 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 26 payments from 9 companies in 2025. Trend: 2023 $411 · 2024 $1,855 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $494 |
| Amgen Inc. | 2 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $131 |
| Lilly USA, LLC | 4 | $92 |
| Novo Nordisk Inc | 2 | $60 |
| Exact Sciences Corporation | 2 | $49 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: BREZTRI, FARXIGA, Otezla, Kerendia, JARDIANCE, Cologuard Collection Kit, MOUNJARO, Ozempic.
Industry payments across CA — which companies pay providers there.
